India may have 500 million doses of coronavirus vaccine by March next year

India’s Economic Times reported on December 14 that considering that four vaccine manufacturers are expected to apply for approval for use in India after completing three phases of clinical trials, nearly 500 million doses of coronavirus vaccines in India may be partially approved by March next year.

According to the report, the Indian pharmaceutical company Zydus Cadila, the Indian biotechnology company Bharat Biotech, the Indian pharmaceutical company Dr Reddys cooperated with the Okamalia Institute, the Indian Serum Institute and AstraZeneca

and the Indian Gen Enterprises or institutions such as nova biopharmaceuticals are expected to submit applications for vaccine use.